EGRX – eagle pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Lifshitz Law PLLC Announces Investigations of Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX), Driven Brands Holdings Inc. (NASDAQ:DRVN), Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS), and Gristone bio, Inc. (NASDAQ:GRTS)
Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Pneumonia Market and Epidemiology Insights 2018-2023 and Outlook 2024-2034 - Featuring Allergan/Pfizer, Merck Sharp and Dohme, Shionogi, Paratek Pharma, Nabriva Therapeutics, and More [Yahoo! Finance]
Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Form 8-K EAGLE PHARMACEUTICALS, For: May 28
Form 8-K EAGLE PHARMACEUTICALS, For: May 20
Form 8-K EAGLE PHARMACEUTICALS, For: May 14
Form NT 10-Q EAGLE PHARMACEUTICALS, For: Mar 31
Form 8-K EAGLE PHARMACEUTICALS, For: Apr 08
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.